Medical Devices Canada

Canada Biosensors Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Canada Biosensors Market Industry Trends and Forecast to 2034: Segmented by (Type, Application, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Canada · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $2.30 Bn Placeholder estimate
Estimate 2025 $2.48 Bn 7.6% of the global market
Projected 2034 $4.91 Bn 98.2% Adds $2.43 Bn over 9 forecast years
CAGR 2025–2034 7.9% Faster than 41% of 173 Medical Devices markets here
Key players 5
  • Canada is 7.58% of the global market.
  • In North America, the largest is US at $12.92 Bn.
  • Fastest growing: Canada (this report) at 7.9% a year.
  • Canada ranks 2nd of 2 by size in North America.

Market size projection

Canada

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$2.43 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Biosensors Market market size by year, Canada
YearMarket sizeChange that yearSince 2025
2024 (estimate) $2.30 Bn — —
2025 (base) $2.48 Bn +$181.3 Mn —
2026 (forecast) $2.67 Bn +$195.7 Mn +7.9%
2027 (forecast) $2.88 Bn +$211.1 Mn +16.4%
2028 (forecast) $3.11 Bn +$227.8 Mn +25.6%
2029 (forecast) $3.36 Bn +$245.8 Mn +35.5%
2030 (forecast) $3.62 Bn +$265.2 Mn +46.3%
2031 (forecast) $3.91 Bn +$286.2 Mn +57.8%
2032 (forecast) $4.22 Bn +$308.8 Mn +70.3%
2033 (forecast) $4.55 Bn +$333.2 Mn +83.7%
2034 (forecast) $4.91 Bn +$359.5 Mn +98.2%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $32.66 Bn
  2. North America $14.87 Bn
  3. US $12.92 Bn
  4. APAC $7.48 Bn
  5. Europe $6.54 Bn
  6. China $2.81 Bn
  7. Canada (this report) $2.48 Bn
  8. Japan $2.22 Bn
  9. Latin America $1.36 Bn
  10. Germany $1.25 Bn
  11. Middle East $1.26 Bn
  12. France $892.2 Mn
  13. Brazil $895.0 Mn
  14. Italy $815.1 Mn
  15. UK $730.8 Mn
  16. India $660.7 Mn
  17. Spain $593.7 Mn
  18. Ecuador $576.0 Mn
  19. Saudi Arabia $572.7 Mn
  20. Africa $465.8 Mn
  21. Mexico $429.4 Mn
  22. Australia $431.9 Mn
  23. Russia $370.0 Mn
  24. New Zealand $366.5 Mn
  25. South Africa $204.6 Mn
  26. UAE $180.9 Mn
  27. Egypt $87.6 Mn
  28. Philippines $72.0 Mn
  29. Malaysia $58.1 Mn
  30. Hong Kong $48.1 Mn
  31. Thailand $44.6 Mn
  32. Singapore $43.4 Mn
  33. Kenya $25.7 Mn

Report snapshot

Canada Biosensors Market Analysis at a glance
Market size, 2025$2.48 Bn placeholder estimate
Forecast, 2034$4.91 Bn placeholder estimate
Growth (CAGR), 2025–20347.9% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsType and application (see all)
Key playersAbbott Laboratories, Medtronic, Dexcom, Inc., Roche, Siemens Healthineers (see all)
Regulator in CanadaHealth CanadaSource: Health Canada. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Canada Biosensors Market Analysis Executive Summary

Biosensors are devices that detect biological signals such as glucose, lactate or heart activity and turn them into data.

Key segments of the biosensors market include type (Electrochemical, Optical and Piezoelectric) and application (Medical, Food Testing and Environmental).

Bar chart: Canada Biosensors market size, 2024–2034, placeholder estimates. $2.30 Bn in 2024, $2.48 Bn in 2025 and $4.91 Bn in 2034, 7.9% CAGR.
Canada Biosensors market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Canada Biosensors Market Dynamics

Market Growth Drivers

Better sensors, longer battery life, smartphone apps and interest in tracking health every day are driving the biosensors market. Doctors are starting to use wearable data in care decisions.

Opportunity

Medical-grade wearables, links to virtual care programs and insurer-funded prevention give the biosensors market strong growth.

Market Restraints

Questions about accuracy, data privacy, limited reimbursement and users who stop wearing devices hold back the biosensors market.

Competitive Landscape for Biosensors Market in Canada

The biosensors market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Biosensors Market in Canada

Biosensors in Canada: rules and payment

Health Canada licenses Class II, III and IV medical devices; Class I devices are sold by companies that hold an establishment licence.⁠[1] Each province and territory runs public health insurance under the Canada Health Act, which covers medically necessary hospital and doctor services.⁠[2]

[1] Health Canada. Checked 14 Nov 2026.

[2] Health Canada. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how biosensors products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Canada.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Biosensors right now, from free public sources.

Latest research 15,962 papers since 2021 (worldwide)

  1. Molecular Biomarkers and Biosensing Innovations for the Early Diagnosis of Ankylosing Spondylitis: From Molecular Mechanisms to Precision Diagnostics. The international journal of biochemistry & cell biology, 2026
  2. Modular nanoplatforms for precision diagnosis and therapy of Alzheimer's disease. Nanomedicine : nanotechnology, biology, and medicine, 2026
  3. Mechanism-guided engineering of production-level-tailored biosensors for high-throughput screening of L-serine producers. Bioresource technology, 2026
  4. Distributed Fiber-Optic Biosensor with BRI Self-Compensation Based on a Step-Tapered Fiber and OFDR for ESCC Dual-Biomarker Detection. ACS sensors, 2026
  5. Phytohormonal regulation of plant immunity under biotic stress: Mechanisms, crosstalk, and sustainable management strategies. Plant physiology and biochemistry : PPB, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Biosensors in context

Canada compared

  • Health spending per person: 6,378 US$ per person (2024). World: 1,317 US$ per person (2023).[1]
  • Doctors: 2.82 per 1,000 people (2023). World: 1.86 per 1,000 people (2022).[2]
  • People aged 65 and over: 20.3% of people (2025). World: 10.4% of people (2025).[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Biosensors market in Canada?
Placeholder estimate: about $2.48 Bn in 2025, rising to about $4.91 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Biosensors market in Canada growing?
Placeholder estimate: about 7.9% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Biosensors market report cover?
The report splits the market by type (Electrochemical, Optical, Piezoelectric, Thermal) and application (Medical, Food Testing, Environmental, Research).
Who are the key players in the Biosensors market?
Key players include Abbott Laboratories, Medtronic, Dexcom, Inc., Roche and Siemens Healthineers.
What is driving the Biosensors market?
Better sensors, longer battery life, smartphone apps and interest in tracking health every day are driving the biosensors market. Doctors are starting to use wearable data in care decisions.
Who regulates Biosensors in Canada?
Health Canada licenses Class II, III and IV medical devices; Class I devices are sold by companies that hold an establishment licence. Source: Health Canada. Checked 14 Nov 2026.
How is healthcare paid for in Canada?
Each province and territory runs public health insurance under the Canada Health Act, which covers medically necessary hospital and doctor services. Source: Health Canada. Checked 14 Nov 2026.
How much research is published on Biosensors?
PubMed lists 15,962 papers on Biosensors added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Biosensors in Canada? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Dermatology Diagnostics: AI and Skin HealthSkin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions… Molecular Point-of-Care Tests: Lab Accuracy, Clinic SpeedTB killed 1.23 million people in 2024. WHO now recommends rapid molecular tests first, bringing lab-grade… Healthcare In-Vitro Diagnostics: What Comes After COVIDCOVID-19 testing created a huge, short-lived spike. Long-term demand for in-vitro diagnostics now comes from…
Back to Catalogue
Keep exploring

Related Medical Devices reports in Canada

See all
Same topic, other categories

Related on diagnostics and lab testing and remote monitoring and wearables

See the topic